Lilly to acquire Verve Therapeutics to advance one-time …
2 days ago · INDIANAPOLIS, June 17, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (Nasdaq: VERV), a Boston -based clinical-stage company …
Beyond Obesity: Eli Lilly’s Genetic Medicine Bet On Verve Therapeutics
1 day ago · The acquisition aligns with Eli Lilly’s broader diversification strategy beyond its core diabetes and obesity treatment portfolio.
Eli Lilly strikes deal to buy Crispr gene-editing biotech Verve
2 days ago · Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Eli Lilly has struck a deal to buy Crispr gene-editing start-up Verve Therapeutics for up to …
Verve Therapeutics Stock Skyrockets On $1.3 Billion Eli Lilly …
2 days ago · Verve Therapeutics stock nearly doubled Tuesday after Eli Lilly agreed to buy the gene-editing company for up to $1.3 billion.
Eli Lilly to acquire Verve Therapeutics for $1.3 billion - CNBC
2 days ago · Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, sending Verve's shares up 77.7% in premarket trading. Lilly has …
Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to …
1 day ago · WEDNESDAY, June 18, 2025 (HealthDay News) — Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about $1 billion upfront.
Eli Lilly to Buy Gene-Editing Biotech Verve for $1.3 Billion - MSN
Eli Lilly & Co. agreed to buy gene-editing biotech company Verve Therapeutics Inc. for $1.3 billion, the drugmaker’s latest investment in an experimental medicine that could fuel its long …
Eli Lilly to acquire Verve Therapeutics for up to $1.3B - Axios
2 days ago · Eli Lilly is acquiring cardiovascular disease drug developer Verve Therapeutics in a deal worth up to $1.3 billion. Why it matters: Biotech M&A activity is heating up, following two …
Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion
2 days ago · Eli Lilly agreed to acquire Verve Therapeutics for approximately $1 billion up front, adding a potential treatment for cardiovascular disease to its portfolio. Under the agreement, …
Eli Lilly to Acquire Verve Therapeutics in $1.3B Deal | Gene …
1 day ago · An announcement by Eli Lilly and Company to acquire Verve Therapeutics, a Boston-based clinical-stage biotechnology organization, in an all-in deal worth up to 1.3 billion will …
- Some results have been removed